143 related articles for article (PubMed ID: 2442112)
1. Interferons in the treatment of multiple myeloma.
Ohno R
Int J Cancer Suppl; 1987; 1():14-20. PubMed ID: 2442112
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon].
Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval T; Gouveia J; Hayat M; Jasmin C; Schwarzenburg L; Machover D; Ribaud P; De Vassal F; Horosezewicz JS
Biomed Pharmacother; 1982 Jan; 36(1):55-9. PubMed ID: 6181822
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial.
Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval T; Gouveia J; Hayat M; Jasmin C; Schwarzenberg L; Machover D; Ribaud P; De Vassal F; Horoszewicz JS
Anticancer Res; 1982; 2(1-2):63-6. PubMed ID: 6180675
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.
Gutterman JU; Blumenschein GR; Alexanian R; Yap HY; Buzdar AU; Cabanillas F; Hortobagyi GN; Hersh EM; Rasmussen SL; Harmon M; Kramer M; Pestka S
Ann Intern Med; 1980 Sep; 93(3):399-406. PubMed ID: 6159812
[TBL] [Abstract][Full Text] [Related]
5. Treatment of multiple myeloma with recombinant interferon alfa-2a.
Ohno R; Kimura K
Cancer; 1986 Apr; 57(8 Suppl):1685-8. PubMed ID: 3948139
[TBL] [Abstract][Full Text] [Related]
6. Bence-Jones myeloma with pleural effusion: response to alpha-interferon and combined chemotherapy.
Makino S; Yamahara S; Nagake Y; Kamura J
Intern Med; 1992 May; 31(5):617-21. PubMed ID: 1504423
[TBL] [Abstract][Full Text] [Related]
7. Interferons in the treatment of multiple myeloma.
Cooper MR; Welander CE
Cancer; 1987 Feb; 59(3 Suppl):594-600. PubMed ID: 3802025
[TBL] [Abstract][Full Text] [Related]
8. Bence Jones proteins and light chains of immunoglobulins. XV. Effect of corticosteroids on synthesis and excretion of Bence Jones protein.
Solomon A
J Clin Invest; 1978 Jan; 61(1):97-108. PubMed ID: 618916
[TBL] [Abstract][Full Text] [Related]
9. Interferons in the treatment of multiple myeloma.
Cooper MR
Semin Oncol; 1986 Sep; 13(3 Suppl 2):13-20. PubMed ID: 3764441
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden.
Ahre A; Björkholm M; Mellstedt H; Brenning G; Engstedt L; Gahrton G; Gyllenhammar H; Holm G; Johansson B; Järnmark M
Cancer Treat Rep; 1984 Nov; 68(11):1331-8. PubMed ID: 6388832
[TBL] [Abstract][Full Text] [Related]
11. Interferon in the treatment of multiple myeloma and the non-Hodgkin's lymphomas.
Wagstaff J; Scarffe JH; Crowther D
Cancer Treat Rev; 1985 Dec; 12 Suppl B():39-44. PubMed ID: 2421896
[No Abstract] [Full Text] [Related]
12. Bence Jones proteins and light chains of immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy.
Solomon A; McLaughlin CL; Capra JD
J Clin Invest; 1975 Mar; 55(3):579-86. PubMed ID: 803979
[TBL] [Abstract][Full Text] [Related]
13. Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.
Oken MM; Kyle RA; Greipp PR; Kay NE; Tsiatis A; Gregory SA; Spiegel R J; O'Connell M J
Leuk Lymphoma; 1996 Feb; 20(5-6):447-52. PubMed ID: 8833401
[TBL] [Abstract][Full Text] [Related]
14. Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferon.
Ohno R; Kodera Y; Ogura M; Murase T; Emi N; Okumura M; Morishita Y; Nagura E; Minami S; Morishima Y
Cancer Chemother Pharmacol; 1985; 14(1):34-7. PubMed ID: 3917376
[TBL] [Abstract][Full Text] [Related]
15. Interferons in the treatment of multiple myeloma.
Cooper MR; Welander CE
Semin Oncol; 1986 Sep; 13(3):334-40. PubMed ID: 2429367
[No Abstract] [Full Text] [Related]
16. Treatment of multiple myeloma with recombinant alpha-interferon.
Quesada JR; Alexanian R; Hawkins M; Barlogie B; Borden E; Itri L; Gutterman JU
Blood; 1986 Feb; 67(2):275-8. PubMed ID: 3942826
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group.
Ann Intern Med; 1996 Jan; 124(2):212-22. PubMed ID: 8533996
[TBL] [Abstract][Full Text] [Related]
18. Interferon therapy in multiple myeloma.
Ideström K; Cantell K; Killander D; Nilsson K; Strander H; Willems J
Acta Med Scand; 1979; 205(3):149-54. PubMed ID: 106625
[TBL] [Abstract][Full Text] [Related]
19. In vivo myelosuppression by combination interferon treatment: antagonism of MuIFN-gamma and MuIFN-beta myelosuppressive effects.
Naldini A; Fleischmann WR
J Biol Response Mod; 1987 Oct; 6(5):546-55. PubMed ID: 3119781
[TBL] [Abstract][Full Text] [Related]
20. Treatments for newly diagnosed multiple myeloma: analysis of survival data and cost-effectiveness evaluation.
Trippoli S; Messori A; Becagli P; Alterini R; Tendi E
Oncol Rep; 1998; 5(6):1475-82. PubMed ID: 9769391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
